Health5 hours ago
GSK Acquires Global Rights for Syndivia’s Advanced Cancer Treatment
GSK plc has secured exclusive worldwide rights from Syndivia to develop and commercialize a preclinical antibody-drug conjugate (ADC) aimed at treating metastatic castration-resistant prostate cancer (mCRPC)....